Samples taken at the 80km CEI*1 in Amman (JOR) on May 21, 2016 from the second-placed horse Obama Al Aswad (FEI ID 104DF50, ridden by Nayef Al Fayez (FEI ID 10066952), have returned positive for the banned substance Boldenone, and the controlled medications Dexamethasone, Meloxicam, Phenylbutazone and its metabolite Oxyphenbutazone.

Boldenone, an anabolic steroid, is a banned substance under the FEI’s Equine Anti-Doping and Controlled Medication Regulations (EADCMRs).

The corticosteroid Dexamethasone is used to treat inflammatory and auto-immune conditions, while the non-steroidal anti-inflammatory drugs Meloxicam, Phenylbutazone and its metabolite Oxyphenbutazone are used for pain relief.

Advertisement